CAS: 1315330-17-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | TL02-59 REF: 54-BUP08946CAS: 1315330-17-6 | - - - | 536,00 €~1.268,00 € | Jue 17 Abr 25 |
 | TL02-59 REF: TM-T13186CAS: 1315330-17-6 | 95.63% | 71,00 €~937,00 € | Mié 18 Jun 25 |
 | 3-(6,7-Dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide REF: 3D-QCC33017CAS: 1315330-17-6 | Min. 95% | - - - | Producto descatalogado |
Ref: 54-BUP08946
| 25mg | 536,00 € | ||
| 50mg | 763,00 € | ||
| 100mg | 1.020,00 € | ||
| 200mg | 1.268,00 € |
Entrega estimada en Estados Unidos, el Jueves 17 de Abril de 2025
TL02-59
CAS:1315330-17-6
TL02-59: Fgr inhibitor (IC50=0.03nM), also targets Lyn (0.1nM), Hck (160nM), halts acute myelogenous leukemia growth.
Fórmula:
C32H34F3N5O4
Pureza:
95.63%
Forma y color:
Solid
Peso molecular:
609.64
- Inhibidores
- Apoptosis
- Tirosina quinasa / adaptadores
- Hck
- Ver más categorías
- Src
Ref: TM-T13186
| 1mg | 71,00 € | ||
| 5mg | 135,00 € | ||
| 10mg | 212,00 € | ||
| 25mg | 359,00 € | ||
| 50mg | 512,00 € | ||
| 100mg | 695,00 € | ||
| 200mg | 937,00 € | ||
| 1mL*10mM (DMSO) | 170,00 € |
Entrega estimada en Estados Unidos, el Miércoles 18 de Junio de 2025
3-(6,7-Dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide
CAS:1315330-17-6
3-(6,7-Dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide is a potent inhibitor of the human TRPV2 ion channel. It has been shown …
Fórmula:
C32H34F3N5O4
Pureza:
Min. 95%
Peso molecular:
609.6 g/mol
Ref: 3D-QCC33017
| 5mg | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información |
